MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0026101
Invision Pharma Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.66 Cr
▲ 29% YoY
Net loss · FY 2024
₹14.28 Lakh
Net margin -3.9%
EBITDA · FY 2024
-₹84,124
EBITDA margin -0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
42
Provident fund records
Directors on board
3
As per MCA filings
About Invision Pharma Limited
Data last updated:
Invision Pharma Limited is a public limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24304KA2018PLC113264. Its GSTIN is 29AAECI8819E1ZB (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nataraj Nanjundappa and Chirag Mukeshkumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bengaluru, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.66 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹14.28 Lakh (net margin -3.9%) and EBITDA of -₹84,124 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.
The company has about 42 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Invision Pharma.
Invision Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0026101). For more details, the company can be reached via its website invisionpharma.com.
Company details
CIN U24304KA2018PLC113264
Registration Number 113264
Incorporation Date 21 May 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0026101
Recognitions & Rankings of Invision Pharma
Contact details
Invision Pharma Limited's registered office is in Bengaluru, Karnataka. Its website is invisionpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor No. 194/31/2/74 – 75 Begur Sub Zone Behind Metro Wholesale Beretena Agrahar, A, Bengaluru, Karnataka, India – 560100
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Invision Pharma Limited, buy the company report.
Comprehensive company report
Invision Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Invision Pharma operates one associated brand: Invision Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Private label manufacturing of nutraceuticals and cosmetics is conducted by Invision Pharma in India and the USA. | invisionpharma.com |
Business activity
The main business activity of Invision Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Invision Pharma Limited, buy the company report.
Financials of Invision Pharma Limited
FY 2025 filings availableInvision Pharma Limited reported revenue of ₹3.66 Cr (up 29% YoY) for FY 2024.
Revenue · FY 2024
₹3.66 Cr ▲ 29%
Net loss · FY 2024
₹14.28 Lakh margin -3.9%
EBITDA · FY 2024
-₹84,124 margin -0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 68%
EBITDA CAGR growth
1 year
▲ 95%
3 years · compounded
▲ 4%
5 years · compounded
▼ 23%
Revenue has grown at a compounded annual rate (CAGR) of 68% over three years, including 29% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.66 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹84,124 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Invision Pharma Limited, buy the company report.
Board of directors of Invision Pharma Limited
Invision Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nataraj Nanjundappa Also directs: Invision Medi Sciences Private Limited | Director | 21 May 2018 | 8 Years 5 Months | Current |
| Chirag Mukeshkumar | Director | 21 May 2018 | 8 Years 5 Months | Current |
| Mukeshkumar | Director | 21 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Invision Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prolife Fine and Specialty Chemicals Private Limited | ₹3.67 Cr (FY 2019) | Ahmedabad, Gujarat, India | ||||
| Eshyasi Pharma Limited | ₹3.66 Cr (FY 2024) | -7.0% | Vadodara, Gujarat, India | |||
| Ravi Plant Biotechnologies Limited | ₹3.66 Cr (FY 2025) | 21.0% | Panchmahals, Gujarat, India | |||
| Invision Pharma Limitedthis company | ₹3.66 Cr (FY 2024) | -₹14.28 Lakh | -3.9% | 29.0% | 42 | Bengaluru, Karnataka, India |
| All-Cure Pharma Private Limited | ₹3.65 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Lord Venky Pharma Pvt Ltd | ₹3.65 Cr (FY 2025) | -9.0% | Yanam, U.T Of, Pondicherry, India |
To see the full peer comparison of Invision Pharma Limited, buy the company report.
Auditor
Invision Pharma Limited is audited by PARASMAL KANKARIYA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARASMAL KANKARIYA | FY 2024 | 022221 |
Shareholding
The shareholding of Invision Pharma Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Invision Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Invision Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Invision Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Invision Pharma Limited has a workforce of 42 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
42
Active EPFO establishments
1
Employee growth
-6.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 42 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Invision Pharma Limited, buy the company report.
GST
Invision Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECI8819E1ZB | Karnataka | Active | 10 Jul 2018 |
To see the full GST registrations and return filing status of Invision Pharma Limited, buy the company report.
Recent activity
Invision Pharma Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Seema ceased to be Director on 29 Mar 2019.
AGM
Invision Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Invision Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Seema ceased to be Director.
Appointed
Chirag Mukeshkumar was appointed as Director.
Appointed
Mukeshkumar was appointed as Director.
Appointed
Nataraj Nanjundappa was appointed as Director.
Incorporation
21 May 2018
Invision Pharma Limited was registered on 21 May 2018 with Roc Bangalore & aged 8 years 5 months as per MCA records.
Frequently asked questions
Invision Pharma is an active public limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 May 2018 (8+ years old) and is registered under CIN U24304KA2018PLC113264.
Invision Pharma has 3 current directors:
- Nataraj Nanjundappa - Director
- Chirag Mukeshkumar - Director
- Mukeshkumar - Director
The latest financial statements of Invision Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Invision Pharma is 29AAECI8819E1ZB, registered in Karnataka.
The CIN (Corporate Identification Number) of Invision Pharma is U24304KA2018PLC113264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invision Pharma was incorporated on 21 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Invision Pharma by revenue are Prolife Fine and Specialty Chemicals Private Limited, Eshyasi Pharma Limited, Ravi Plant Biotechnologies Limited, All-Cure Pharma Private Limited, Lord Venky Pharma Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Seema ceased to be Director on 29 Mar 2019. Chirag Mukeshkumar was appointed as Director on 21 May 2018. Mukeshkumar was appointed as Director on 21 May 2018. Invision Pharma has 4 board changes on record in total.
Yes, Invision Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0026101).
Invision Pharma can be reached through the website invisionpharma.com. Its registered office is in Bengaluru, Karnataka, India.
The registered office of Invision Pharma is at 1st Floor No. 19431274 – 75 Begur Sub Zone Behind Metro Wholesale Beretena Agrahar, A, Bengaluru, Karnataka, India – 560100.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages